RE:Reason for the recent rise in SP
Thanks Jaro...always nice to get new investor eyes on our progress/data. Now just need those new eyes to look behind the presented data to understand the true potential. For the new eyes only....that 90 day pie chart showing the clinical response data was based on the original clinical protocol that has since been modified. Unfortunately, the original protocol led to the under treatment of the first 12 patients enrolled, & of those 12, four were removed. Fortunately, this oversight in protocol was caught early & appropriate treatment optimizations were made...as well as changes made to the original patient withdrawal criteria. If the since updated withdrawal criteria had originally been in place, all four patients that were previously removed would now be considered eligible for the second treatment. There is a primary treatment at day 0 & a secondary treatment at day 180. I also noted the article didnt show the more promising 180 day pie chart. Of the 9 remaining patients (thats 9 out of a total of 14...though if you were to apply the updated criteria, the actual number could have been 13 patients remaining out of 14), the 180 day pie chart reflected an increase in CR from 34% at 90 days to 45% at the 180 day assessment. Despite following the original deficient protocol, those are very respectable/competitive percentages. In other words, I expect CRs will increase even more dramatically now that ALL patients are receiving first & second treatments that are both optimized. GLTA longs!